Correlation Between Travere Therapeutics and Bluebird Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Bluebird Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Bluebird Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Bluebird bio, you can compare the effects of market volatilities on Travere Therapeutics and Bluebird Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Bluebird Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Bluebird Bio.

Diversification Opportunities for Travere Therapeutics and Bluebird Bio

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Travere and Bluebird is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Bluebird bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluebird bio and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Bluebird Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluebird bio has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Bluebird Bio go up and down completely randomly.

Pair Corralation between Travere Therapeutics and Bluebird Bio

Given the investment horizon of 90 days Travere Therapeutics is expected to generate 0.54 times more return on investment than Bluebird Bio. However, Travere Therapeutics is 1.84 times less risky than Bluebird Bio. It trades about 0.03 of its potential returns per unit of risk. Bluebird bio is currently generating about -0.03 per unit of risk. If you would invest  2,130  in Travere Therapeutics on November 9, 2024 and sell it today you would earn a total of  56.00  from holding Travere Therapeutics or generate 2.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Travere Therapeutics  vs.  Bluebird bio

 Performance 
       Timeline  
Travere Therapeutics 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Bluebird bio 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bluebird bio are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Bluebird Bio exhibited solid returns over the last few months and may actually be approaching a breakup point.

Travere Therapeutics and Bluebird Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Travere Therapeutics and Bluebird Bio

The main advantage of trading using opposite Travere Therapeutics and Bluebird Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Bluebird Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will offset losses from the drop in Bluebird Bio's long position.
The idea behind Travere Therapeutics and Bluebird bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins